Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Radiography (plain film, excretory urography [EU], retrograde pyelography, cystography)
Ultrasonography (US)
Computed tomography (CT) scan
Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA)
Radionuclide imaging
Kidney angiography
The plain abdominal radiograph, also called kidneys, ureters, bladder, can show the following:
Calcifications: kidney calculus, calcified neoplasm, sloughed papilla, medullary or cortical nephrocalcinosis, ureteric or bladder calculus/tumor
Air: air within or adjacent to the kidneys from severe infection
Soft tissue changes: obliteration of the psoas or kidney outline may indicate inflammation or tumor
Bone: changes of renal osteodystrophy and either lytic or blastic metastasis
EU is also known as an intravenous pyelogram
The EU used to be the initial modality for upper tract imaging in patients with hematuria, flank pain, and other urologic disease
Now replaced by ultrasound, CT urography, and MR urography in most medical centers
Less sensitive than US, CT, or MRI for detecting kidney masses
EU does not allow reliable differentiation of solid masses from cysts
The injection of contrast material directly into the distal ureter or the ureteral orifice of the bladder for visualization of the collecting system and ureter, without relying on the ability of the kidneys to excrete contrast media. The primary use of retrograde pyelography is to evaluate suspected ureteral obstruction or ureteral urothelial cancer in a patient whose ability to excrete contrast material is significantly impaired.
This is an adjunctive technique when conventional imaging studies fail to adequately demonstrate the suspected pathology. Retrograde pyelography does not evaluate the kidney parenchyma and requires cystoscopy to place the catheters. This procedure is usually performed by a urologist.
An alternative to the retrograde pyelography is antegrade pyelography, usually performed by an interventional radiologist. A percutaneous needle is placed into the kidney collecting system, and contrast is injected.
Comprehensive upper tract imaging includes the following:
Unenhanced axial CT of the kidneys—detection of calcification and baseline density measurement to determine enhancement of masses
Enhanced CT of the abdomen and pelvis with corticomedullary phase (early enhancement of the cortical tissue) and nephrographic phase (delayed imaging to view opacification of the medullary pyramids before calyceal excretion) for detection of enhancement of kidney masses
Excretory phase imaging of the abdomen and pelvis obtained with delayed imaging once contrast is in the collecting system essential for assessing subtle urothelial abnormalities including urothelial tumors; papillary necrosis; calyceal deformity; ureteral stricture; and inflammatory changes of the kidney collecting systems, ureters, and bladder
CT images may be reviewed as two-dimensional and three-dimensional reformatted images
Estimating kidney size
Assessing the echogenicity of the kidney (increased echogenicity may indicate chronic kidney disease but is nonspecific)
Preferred screening modality for suspected obstruction because it is very sensitive to dilatation of the collecting system, such as from obstruction in kidney failure, pelvic neoplasm, in kidney transplant, and in acute urinary tract infection with pyonephrosis
Complete ureteral obstruction can be excluded by documenting the presence of a ureteral jet (color flow seen on Doppler ultrasound as urine passes into the bladder from the ureteral orifice)
Can detect kidney calculi as echogenic foci with shadowing
Can differentiate solid from cystic mass
Diagnosing adult polycystic kidney disease and screening involved families
Guiding interventional procedures such as kidney biopsy and cyst aspiration
Detecting perinephric fluid collections
Evaluating kidney transplant allograft
Evaluating parenchymal echogenicity and masses
Detecting perinephric fluid collections (seroma, hematoma, urinoma, lymphocele)
Looking for hydronephrosis
Diagnosing ureteral obstruction/stenosis
Using Doppler to look for vascular compromise/complications
Used to guide for biopsies, aspiration, and drainage
Using resistive index to look for rejection.
Sensitive for detection of perirenal fluid collections, pelvicalyceal dilatation, and cysts
Differentiates cortex and medulla
Differentiates cystic and solid masses
Shows the kidney contour and perinephric space
Demonstrates kidney blood flow by Doppler technique
Provides good kidney imaging irrespective of kidney function; may be used in patients with elevated serum creatinine
Can evaluate resistive indices to monitor chronic kidney disease and kidney transplants
Can be used portably at the bedside in the intensive care unit
Safe: no ionizing radiation or nephrotoxic contrast medium
Low cost
Does not show fine pelvicalyceal detail
Does not show the entire normal ureter, although it may occasionally see proximal or distal ureters
Sometimes there is a limited acoustic window for seeing kidneys, especially on the left
Does not show the entire retroperitoneum
Can miss small kidney calculi and most ureteral calculi
Gives no functional information
Operator dependent
For evaluation of an indeterminate mass on US or a solid mass when neoplasm is suspected
CT can define the extent of a neoplasm, evaluate for lymph node involvement, give a more comprehensive view of the perirenal, pararenal spaces, and Gerota fascia, evaluate vasculature (renal vein/inferior vena cava involvement), and stage neoplasms.
CT is the imaging method of choice in the evaluation of suspected kidney trauma.
CT provides information on the retroperitoneum and adrenal glands.
Complications of obstruction, such as infection, calyceal rupture, and kidney cortical atrophy, are readily seen.
In 1986 Bosniak proposed a classification to characterize cystic kidney masses detected by CT scan as “nonsurgical” (i.e., benign) or “surgical” (i.e., requiring surgery). In his original classification, there were four categories:
Category I: simple benign cysts (fluid-filled, no perceptible wall)
Category II: benign cystic lesions that are minimally complicated (mural calcifications, few thin septations)
Category IIF—added in 1993 (F = follow-up): more numerous thin septations, slight cyst wall thickening, totally intrarenal, nonenhancing, high-density lesions (i.e., hyperdense cysts)
Category III: more complicated cystic lesions (calcifications, thickened or numerous septations, enhancement of the septations, mural nodules, thickened, irregular wall)
Category IV: lesions that are clearly malignant cystic carcinomas (mural nodules with vascularization, enhancement of solid components)
Categories I and II are considered nonsurgical, whereas categories III and IV are surgical. The risk that a category III or IV lesion is malignant is approximately 50% (range, 25% to 100%). The risk of malignancy in a Bosniak IIF cystic lesion is approximately 5%.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here